CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-16
DOI
10.1038/s41598-021-85379-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5′-nucleotidase (CD73) Inhibitors with Variable Binding Modes
- (2020) Sanjay Bhattarai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pembrolizumab for Early Triple-Negative Breast Cancer
- (2020) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression
- (2020) Charlotte Levin Tykjær Jørgensen et al. BREAST CANCER RESEARCH AND TREATMENT
- Compartmentalization of adenosine metabolism in cancer cells and its modulation during acute hypoxia
- (2020) Karolina Losenkova et al. JOURNAL OF CELL SCIENCE
- CD73 promotes tumor metastasis by modulating RICS/RhoA signaling and EMT in gastric cancer
- (2020) Zhijun Xu et al. Cell Death & Disease
- CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
- (2020) Jerry B. Harvey et al. Frontiers in Immunology
- Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ecto-Nucleotidases CD73 and CD39
- (2020) Jenna L. Jeffrey et al. JOURNAL OF MEDICINAL CHEMISTRY
- The ARRIVE guidelines 2.0: updated guidelines for reporting animal research
- (2020) Nathalie Percie du Sert et al. JOURNAL OF PHYSIOLOGY-LONDON
- The adenosine pathway in immuno-oncology
- (2020) Bertrand Allard et al. Nature Reviews Clinical Oncology
- Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
- (2019) Oscar M. Rueda et al. NATURE
- A Novel Specific Anti-CD73 Antibody Inhibits Triple-Negative Breast Cancer Cell Motility by Regulating Autophagy
- (2019) Zheng Qiao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Highly‐expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β‐catenin and mTOR/HIF1α/VEGF signaling
- (2019) Yingchi Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Blockade pf CD73/adenosine axis improves the therapeutic efficacy of docetaxel in epithelial ovarian cancer
- (2019) Hongmei Li et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis
- (2019) Xiao-Lu Ma et al. Journal of Hematology & Oncology
- Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
- (2019) Simone de Leve et al. Frontiers in Immunology
- Adenosine Metabolism: Emerging Concepts for Cancer Therapy
- (2019) Detlev Boison et al. CANCER CELL
- Chemotherapy induces enrichment of CD47+/CD73+/PDL1+immune evasive triple-negative breast cancer cells
- (2018) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stretching Reduces Tumor Growth in a Mouse Breast Cancer Model
- (2018) L. Berrueta et al. Scientific Reports
- Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface
- (2018) Rahila Rahimova et al. PLoS Computational Biology
- The A2B Adenosine Receptor Modulates the Epithelial– Mesenchymal Transition through the Balance of cAMP/PKA and MAPK/ERK Pathway Activation in Human Epithelial Lung Cells
- (2018) Chiara Giacomelli et al. Frontiers in Pharmacology
- CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells
- (2018) Michela Lupia et al. Stem Cell Reports
- Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
- (2018) Mihriban Karaayvaz et al. Nature Communications
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT-related genes Snail and E-cadherin
- (2017) Ying Qiu et al. ONCOLOGY REPORTS
- QuPath: Open source software for digital pathology image analysis
- (2017) Peter Bankhead et al. Scientific Reports
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Nucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT)
- (2016) A. S. Martínez-Ramírez et al. Purinergic Signalling
- The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
- (2016) Bernard Pereira et al. Nature Communications
- CD73 is associated with poor prognosis in HNSCC
- (2016) Zhen-Hu Ren et al. Oncotarget
- α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5′-Nucleotidase (CD73) Inhibitors
- (2015) Sanjay Bhattarai et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Clinical Importance of Assessing Tumor Hypoxia: Relationship of Tumor Hypoxia to Prognosis and Therapeutic Opportunities
- (2014) Joseph C. Walsh et al. ANTIOXIDANTS & REDOX SIGNALING
- Enzymes involved in metabolism of extracellular nucleotides and nucleosides: Functional implications and measurement of activities
- (2014) Gennady G. Yegutkin CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Quantification of Dynamic Morphological Drug Responses in 3D Organotypic Cell Cultures by Automated Image Analysis
- (2014) Ville Härmä et al. PLoS One
- Anti-CD73 therapy impairs tumor angiogenesis
- (2013) Bertrand Allard et al. INTERNATIONAL JOURNAL OF CANCER
- CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
- (2013) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD39 and CD73 in immunity and inflammation
- (2013) Luca Antonioli et al. TRENDS IN MOLECULAR MEDICINE
- Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
- (2012) A. K. Azab et al. BLOOD
- Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer
- (2012) Johanna Tuomela et al. BREAST CANCER RESEARCH AND TREATMENT
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Cellular function and molecular structure of ecto-nucleotidases
- (2012) Herbert Zimmermann et al. Purinergic Signalling
- CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice
- (2011) Long Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- A Comprehensive Panel of Three-Dimensional Models for Studies of Prostate Cancer Growth, Invasion and Drug Responses
- (2010) Ville Härmä et al. PLoS One
- Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
- (2010) J. Stagg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer
- (2009) K Lundgren et al. BRITISH JOURNAL OF CANCER
- Hypoxia in microscopic tumors
- (2008) Xiao-Feng Li et al. CANCER LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More